Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Savlon is a prominent brand of antiseptic and personal care products, primarily known for its efficacy in first aid and hygiene. Originally developed by Imperial Chemical Industries (ICI) in the 1950s, the brand's rights are currently split, with ITC Limited owning the brand in India and Johnson & Johnson managing it globally. The product portfolio is centered around antiseptic liquids, soaps, and handwashes that utilize active ingredients like chlorhexidine gluconate and cetrimide. Savlon distinguishes itself in the market through its tough on germs, gentle on skin positioning, catering to both household and clinical environments. In recent years, the brand has expanded into advanced categories such as disinfectant sprays, fabric disinfectants, and specialized wound healing patches. As a commercially mature entity, Savlon continues to innovate within the consumer healthcare space to address evolving public health needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Savlon.